Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

460
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
460
Behavior Therapy01:22

Behavior Therapy

732
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
732
Drug Therapy01:28

Drug Therapy

304
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
304
Cognitive Therapy01:25

Cognitive Therapy

1.3K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thin and in situ melanoma: an update for the dermatologist.

Anais brasileiros de dermatologia·2026
Same author

Kaposiform hemangioendothelioma associated with coagulopathy and treated with low-dose aspirin - A three-case series.

Anais brasileiros de dermatologia·2026
Same author

Validation of PARACELSUS score performance for the diagnosis of pyoderma gangrenosum: An international multicenter study with 1403 cases.

Journal of the American Academy of Dermatology·2026
Same author

Risk factors and surgical outcomes in periocular basal cell carcinoma treated with Mohs micrographic surgery.

Anais brasileiros de dermatologia·2026
Same author

Plantar acral melanoma: epidemiological, clinical, dermoscopic and histopathological features. A Brazilian cohort.

Anais brasileiros de dermatologia·2024
Same author

Unresectable auricular squamous cell carcinoma with locoregional metastasis: use of cemiplimab in an immunosuppressed patient.

Anais brasileiros de dermatologia·2023
Same journal

Correlation between invasion front and survival of patients with cutaneous melanomas.

Anais brasileiros de dermatologia·2026
Same journal

Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence.

Anais brasileiros de dermatologia·2026
Same journal

Pediatric psoriasis: from immunogenetics to targeted therapies.

Anais brasileiros de dermatologia·2026
Same journal

Perifollicular fibrosis and inflammation in androgenetic alopecia and seborrheic dermatitis: diagnostic challenges in differentiation from fibrosing alopecia in a pattern distribution.

Anais brasileiros de dermatologia·2026
Same journal

Exuberant cutaneous lymphoepithelioma-like carcinoma: clinicopathological correlation in an aggressive case<sup>⋆</sup>.

Anais brasileiros de dermatologia·2026
Same journal

Tumor-like periungual cutaneous sporotrichosis in an endemic area.

Anais brasileiros de dermatologia·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.2K

New and developing therapies for atopic dermatitis.

Tamar Hajar1, João Renato Vianna Gontijo1, Jon M Hanifin1

  • 1Department of Dermatology, Oregon Health and Science University - Portland OR, USA.

Anais Brasileiros De Dermatologia
|April 12, 2018
PubMed
Summary
This summary is machine-generated.

New therapies are emerging for atopic dermatitis, a common inflammatory skin condition. These advancements offer hope for better management, especially for severe cases unresponsive to current treatments.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.5K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Related Experiment Videos

Last Updated: Feb 12, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.2K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.5K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis is a prevalent inflammatory skin condition.
  • Recent insights into disease pathogenesis are driving pharmaceutical innovation.
  • Current treatments face limitations, particularly for severe or recalcitrant cases.

Purpose of the Study:

  • To review emerging therapeutic strategies for atopic dermatitis.
  • To highlight the potential of new drugs in addressing unmet needs.
  • To discuss advancements in managing this complex skin disease.

Main Methods:

  • Literature review of recent studies on atopic dermatitis pathogenesis and treatment.
  • Analysis of data from clinical trials of novel therapeutic agents.
  • Synthesis of information on the efficacy and safety of developing therapies.

Main Results:

  • Numerous promising new drugs for atopic dermatitis are in development.
  • Novel topical agents show potential as alternatives to chronic corticosteroid use, especially in children.
  • Significant unmet needs persist for patients with severe or recalcitrant atopic dermatitis.

Conclusions:

  • Developing therapies offer substantial promise for improving atopic dermatitis management.
  • New treatments may provide crucial alternatives for patients with limited options.
  • Continued research is vital for advancing the care of atopic dermatitis.